CareFusion Reports First Quarter Results, Raises Full-Ye...($0.25 $0.14 Discontinue...),Health

Date:11/5/2009

$0.25 $0.14 Discontinued Operations $0.12 $0.38 Diluted Earnings per Common Share $0.37 $0.51 Weighted-Average Number of Shares Outstanding Basic 220.6 220.5 Diluted 221.2 220.5 (1) Earnings per share calculations are performed separately for each component presented. Therefore, the sum of the per share components from the table may not equal the per share amount presented.

                             CAREFUSION CORPORATION
                         ADJUSTED FINANCIAL INFORMATION
                                  (UNAUDITED)

                                         Quarter Ended September 30, 2009
                                      ---------------------------------------
    (in millions, except per                Discontinued  One-time
     common share amounts)            GAAP  Operations(1) Items(2) Adjusted(3)
    -------------------------------------------------------------------------

    Revenue                           $923        $-         $-       $923
    Cost of Products Sold              472         -          -        472
                                       ---       ---        ---        ---
    Gross Margin                       451         -          -        451

    Selling, General and
     Administrative Expenses           297         -        (16)       281
    Research and Development
     Expenses                           36         -          -         36
    Restructuring and Acquisition
     Integration Charges                 1         -         (1)         -
                                       ---       ---        ---        ---
    Operating Income                   117         -         17        134

    Interest Expense and Other, Net     42         -        (22)        20
            
'/>"/>
SOURCE  CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 
Related medicine technology :

1. CareFusion Earns Top Ranking in MD Buyline and KLAS Reports
2. CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010
3. CareFusion Shipping Ventilators to CDC for National Emergency Preparedness
4. CareFusion Moves First Quarter Earnings Announcement to November 5
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. Spherix Reports Second Quarter Earnings
7. Tapestry Reports Second Quarter 2007 Results
8. Callisto Reports on Second-Quarter 2007 Milestones
9. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress